Sutro Biopharma registers Phase 1 first-in-human trial of ADC STRO-006 in solid tumorsSep 8Trial updateSTRO-006Sutro Biopharma, Inc.
Sutro Biopharma posts early STRO-004 responses, updates Q2 2026 financialsAug 12Clinical readoutSTRO-004Sutro Biopharma, Inc.
Sign inSign in